Works matching DE "CEMIPLIMAB"

Results: 115

Top advances of the year: Developments of immunotherapy in cutaneous squamous cell carcinoma, 2023–2024.

Published in:

Cancer (0008543X), 2025, v. 131, n. 11, p. 1, doi. 10.1002/cncr.35920

By:

Trinconi Cunha, Mateus;
Wallace, Neil;
Porceddu, Sandro;
Ferrarotto, Renata

Publication type:

Article

Current treatment options for locally advanced and metastatic basal cell carcinoma. A narrative review.

Published in:

Expert Review of Anticancer Therapy, 2025, v. 25, n. 6, p. 621, doi. 10.1080/14737140.2025.2498999

By:

Absil, Gilles;
Rorive, Andrée;
Marchal, Nathalie;
Piret, Pascal;
Nikkels, Arjen F.

Publication type:

Article

Fortgeschrittenes Plattenepithelkarzinom, das sich auf einer chronischen Hidradenitis suppurativa entwickelt hat und erfolgreich mit Cemiplimab behandelt wurde: ein Fallbericht.

Published in:

Kompass Dermatologie, 2025, v. 13, n. 1, p. 49, doi. 10.1159/000543375

By:

Ruggiero, Angelo;
Lauro, Wanda;
Miano, Chiara;
Villani, Alessia;
Fabbrocini, Gabriella;
Marasca, Claudio

Publication type:

Article

Kutanes Plattenepithelkarzinom: Fortschritte in der neoadjuvanten Immuntherapie mit Cemiplimab.

Published in:

Kompass Dermatologie, 2024, v. 12, n. 3, p. 153, doi. 10.1159/000539925

By:

Alter, Mareike

Publication type:

Article

Immunotherapy in advanced cutaneous squamous cell carcinoma: Sydney west cancer network experience.

Published in:

ANZ Journal of Surgery, 2023, v. 93, n. 1/2, p. 235, doi. 10.1111/ans.18219

By:

Hasmat, Shaheen;
Howle, Julie R.;
Carlino, Matteo S.;
Sundaresan, Puma;
Veness, Michael J.

Publication type:

Article

Posterior Uveitis Associated with Cemiplimab.

Published in:

Ocular Immunology & Inflammation, 2022, v. 30, n. 5, p. 1211, doi. 10.1080/09273948.2021.1872649

By:

Dow, Eliot R.;
Hou, Kirk;
Ransome, Susan;
Abbassi, Sam;
Tsui, Edmund

Publication type:

Article

Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus.

Published in:

Clinical & Experimental Dermatology, 2022, v. 47, n. 3, p. 608, doi. 10.1111/ced.15018

By:

Gambichler, T.;
Hessam, S.;
Lüttringhaus, T.;
Boms, S.

Publication type:

Article

Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.

Published in:

Clinical & Experimental Dermatology, 2021, v. 46, n. 8, p. 1612, doi. 10.1111/ced.14804

By:

De Giorgi, V.;
Trane, L.;
Savarese, I.;
Silvestri, F.;
Venturi, F.;
Zuccaro, B.;
Scarfì, F.

Publication type:

Article

Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma.

Published in:

Drugs, 2020, v. 80, n. 8, p. 813, doi. 10.1007/s40265-020-01302-2

By:

Lee, Arnold;
Duggan, Sean;
Deeks, Emma D.

Publication type:

Article

Advanced Squamous Cell Carcinoma Developed on Chronic Hidradenitis Suppurativa, Successfully Treated with Cemiplimab: A Case Report.

Published in:

2023

By:

Ruggiero, Angelo;
Lauro, Wanda;
Miano, Chiara;
Villani, Alessia;
Fabbrocini, Gabriella;
Marasca, Claudio

Publication type:

Case Study

Oral ulcers and sarcoid-like reaction in lymph nodes after cemiplimab therapy for locally advanced cutaneous squamous cell carcinoma: a case report.

Published in:

Einstein (16794508), 2022, v. 20, p. 1, doi. 10.31744/einstein_journal/2022RC6367

By:

Henriques Ferreira, Mariana;
Mello Bezinelli, Letícia;
de Paula Eduardo, Fernanda;
Ferreira Gobbi, Marcella;
Corrêa, Luciana;
Schvartsman, Gustavo

Publication type:

Article

A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.

Published in:

Hematological Oncology, 2023, v. 41, n. 1, p. 108, doi. 10.1002/hon.3089

By:

Carlo‐Stella, Carmelo;
Zinzani, Pier Luigi;
Sureda, Anna;
Araújo, Luis;
Casasnovas, Olivier;
Carpio, Cecilia;
Yeh, Su‐Peng;
Bouabdallah, Krimo;
Cartron, Guillaume;
Kim, Won Seog;
Cordoba, Raul;
Koh, Youngil;
Re, Alessandro;
Alves, Daniela;
Chamuleau, Martine;
Le Gouill, Steven;
López‐Guillermo, Armando;
Moreira, Ilídia;
van der Poel, Marjolein W. M.;
Abbadessa, Giovanni

Publication type:

Article

Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03700-x

By:

Bailly-Caillé, Barbara;
Levard, Romain;
Kottler, Diane;
Dompmartin, Anne;
L'Orphelin, Jean-Matthieu

Publication type:

Article

Inoperable poorly differentiated SCC to vertex of scalp progressing into sagittal sinus treated with palliative Cemiplimab.

Published in:

2022

By:

Grounds, Katie;
Emmanuel, O

Publication type:

Case Study

Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report.

Published in:

2021

By:

Alloghbi, Abdurahman;
Ninia, James;
Alshare, Bayan;
Hotaling, Jeffrey;
Raza, Syed;
Sukari, Ammar

Publication type:

Case Study

Population pharmacokinetics modeling and exposure‐response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2022, v. 11, n. 11, p. 1458, doi. 10.1002/psp4.12855

By:

Nguyen, Jenny‐Hoa;
Epling, Daniel;
Dolphin, Nancy;
Paccaly, Anne;
Conrado, Daniela;
Davis, John D.;
Al‐Huniti, Nidal

Publication type:

Article

Pressure increases PD-L1 expression in A549 lung adenocarcinoma cells and causes resistance to anti-ROR1 CAR T cell-mediated cytotoxicity.

Published in:

Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10905-6

By:

Ou, Zhenglin;
Dou, Xiaolin;
Tang, Neng;
Liu, Guodong

Publication type:

Article

The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1171302

By:

Tingting Lu;
Yufan Huang;
Zhongjie Cai;
Wangchun Lin;
Xiaoxiao Chen;
Ruijia Chen;
Yingying Hu

Publication type:

Article

Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab).

Published in:

Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1408667

By:

Challapalli, Amarnath;
Stewart, Grant;
Shaw, Heather;
Davies, Peter John;
Lopez-Baez, Juan Carlos;
Ottley, Edward C.;
Kelly, Stephen

Publication type:

Article

Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report.

Published in:

2023

By:

Passarelli, Anna;
Pisano, Carmela;
Coppola, Elisabetta;
Ventriglia, Jole;
Cecere, Sabrina Chiara;
Di Napoli, Marilena;
Carideo, Luciano;
Lastoria, Secondo;
Pignata, Sandro

Publication type:

Case Study

Cemiplimab for metastatic squamous cell carcinoma of the orbit, periocular adnexa, and thigh.

Published in:

2024

By:

Dhillon, Jobanpreet;
Li, Daniel Q.;
Burnier, Miguel;
Shenouda, George;
Arthurs, Bryan P.;
El-Hadad, Christian

Publication type:

Case Study

Management of periocular cutaneous squamous cell carcinoma with perineural invasion: a case series and literature review.

Published in:

Orbit, 2022, v. 41, n. 1, p. 34, doi. 10.1080/01676830.2021.1893342

By:

Clark, Thomas J. E.;
Harris, Gerald J.

Publication type:

Article

Bilateral Diffuse Uveal Melanocytic Proliferation in a Woman with Metastatic Scalp Squamous Cell Carcinoma Treated with Cemiplimab.

Published in:

2021

By:

Katzburg, Etti;
Zur, Dinah;
Gutfeld, Orit;
Kirgner, Ilya;
Habot-Wilner, Zohar

Publication type:

Case Study

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy.

Published in:

2025

By:

Lambert-Swainston, Chalette;
Samlowski, Wolfram;
Reynolds, Brandon;
Hedayat, Amin

Publication type:

Case Study

Cutaneous Squamous Cell Carcinoma with Signet-Ring Cell Component and CDX2 Expression in a Patient Treated with PD-1 Inhibitor: A Case Report of a Common Tumor with Unusual Differentiation.

Published in:

2023

By:

Zada, Sherehan;
Tao, Jeremiah;
Estopinal, Maria Del Valle

Publication type:

Case Study

Managing Advanced Basal Cell Carcinoma: A Guide for the Dermatology Clinician.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2025, v. 18, n. 3, p. 21

By:

Burshtein, Joshua;
Schlesinger, Todd

Publication type:

Article

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

Published in:

Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-03971-5

By:

Mallardo, Domenico;
Simeone, Ester;
Festino, Lucia;
Tuffanelli, Marilena;
Vanella, Vito;
Trojaniello, Claudia;
Vitale, Maria Grazia;
Ottaviano, Margaret;
Capone, Mariaelena;
Madonna, Gabriele;
Sparano, Francesca;
Cioli, Eleonora;
Scarpato, Luigi;
Palla, Marco;
Di Trolio, Rossella;
Meinardi, Paolo;
Caracò, Corrado;
Ferrara, Gerardo;
Muto, Paolo;
Cavalcanti, Ernesta

Publication type:

Article

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.

Published in:

Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-03971-5

By:

Mallardo, Domenico;
Simeone, Ester;
Festino, Lucia;
Tuffanelli, Marilena;
Vanella, Vito;
Trojaniello, Claudia;
Vitale, Maria Grazia;
Ottaviano, Margaret;
Capone, Mariaelena;
Madonna, Gabriele;
Sparano, Francesca;
Cioli, Eleonora;
Scarpato, Luigi;
Palla, Marco;
Di Trolio, Rossella;
Meinardi, Paolo;
Caracò, Corrado;
Ferrara, Gerardo;
Muto, Paolo;
Cavalcanti, Ernesta

Publication type:

Article

Cemiplimab.

Published in:: Australian Prescriber, 2022, v. 45, n. 4, p. 136, doi. 10.18773/austprescr.2022.050
Publication type:: Article

Dose exploration results from Phase 1 study of cemiplimab, a human monoclonal programmed death (PD)-1 antibody, in Japanese patients with advanced malignancies.

Published in:

2021

By:

Kitano, Shigehisa;
Shimizu, Toshio;
Koyama, Takafumi;
Ebata, Takahiro;
Iwasa, Satoru;
Kondo, Shunsuke;
Shimomura, Akihiko;
Fujiwara, Yutaka;
Yamamoto, Noboru;
Paccaly, Anne;
Li, Siyu;
Rietschel, Petra;
Sims, Tasha

Publication type:

journal article

Cemiplimab Improves Survival versus Chemotherapy in Patients with Advanced NSCLC and PD-L1 ≥50%.

Published in:: Value-Based Cancer Care, 2020, v. 11, n. 6, p. 40
Publication type:: Article

LIBTAYO<sup>®</sup> (cemiplimab-rwlc) injection 350mg.

Published in:: Value-Based Cancer Care, 2020, v. 11, n. 5, p. 24
Publication type:: Article

Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma.

Published in:

Value-Based Cancer Care, 2020, v. 11, n. 4, p. 7

By:

Doyle, Chase

Publication type:

Article

Libtayo plus Platinum-Based Chemotherapy Now FDA Approved for NSCLC without Genomic Aberrations.

Published in:: Oncology Practice Management, 2023, v. 13, n. 1, p. 19
Publication type:: Article

Regeneron and Sanofi Genzyme's Libtayo Surround Program.

Published in:: 2020
Publication type:: Product Review

Cemiplimab Cost-Effective for Advanced Cutaneous Squamous-Cell Carcinoma.

Published in:

Oncology Practice Management, 2020, v. 10, n. 8, p. 33

By:

Dawson, Charlie

Publication type:

Article

Regeneron's Libtayo Surround Program.

Published in:: Oncology Practice Management, 2019, p. 98
Publication type:: Article

Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer.

Published in:

Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1113374

By:

Xueyan Liang;
Xiaoyu Chen;
Huijuan Li;
Yan Li

Publication type:

Article

The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports.

Published in:

Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1111146

By:

Colombo, Elena;
Gurizzan, Cristina;
Ottini, Arianna;
Caspani, Francesca;
Bergamini, Cristiana;
Locati, Laura D.;
Marchiselli, Chiara;
Alberti, Andrea;
Lorini, Luigi;
Licitra, Lisa F.;
Bossi, Paolo;
Resteghini, Carlo

Publication type:

Article

The current clinical approach to difficult-to-treat basal cell carcinomas.

Published in:

Expert Review of Anticancer Therapy, 2023, v. 23, n. 1, p. 43, doi. 10.1080/14737140.2023.2161517

By:

Di Brizzi, Eugenia Veronica;
Argenziano, Giuseppe;
Brancaccio, Gabriella;
Scharf, Camila;
Ronchi, Andrea;
Moscarella, Elvira

Publication type:

Article

Cemiplimab for locally advanced and metastatic basal cell carcinoma.

Published in:

Expert Review of Anticancer Therapy, 2022, v. 22, n. 3, p. 243, doi. 10.1080/14737140.2022.2043748

By:

Damsin, Thomas;
Lebas, Eve;
Marchal, Nathalie;
Rorive, Andrée;
Nikkels, Arjen F

Publication type:

Article

Combination regimens and immunologic mechanisms to enhance the efficacy of cemiplimab for cutaneous squamous cell carcinoma.

Published in:

Expert Review of Anticancer Therapy, 2022, v. 22, n. 2, p. 237, doi. 10.1080/14737140.2022.2020652

By:

Hanania, Hannah L.;
Lewis, Daniel J.

Publication type:

Article

Comprehensive Evaluation of Anti-PD-1, Anti-PD-L1, Anti-CTLA-4 and Their Combined Immunotherapy in Clinical Trials: A Systematic Review and Meta-analysis.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.883655

By:

Xiang, Ze;
Li, Jiayuan;
Zhang, Zhengyu;
Cen, Chao;
Chen, Wei;
Jiang, Bin;
Meng, Yiling;
Wang, Ying;
Berglund, Björn;
Zhai, Guanghua;
Wu, Jian

Publication type:

Article

Cemiplimab for Locally Advanced and Metastatic Cutaneous Squamous-Cell Carcinomas: Real-Life Experience from the French CAREPI Study Group.

Published in:

Cancers, 2021, v. 13, n. 14, p. 3547, doi. 10.3390/cancers13143547

By:

Hober, Candice;
Fredeau, Lisa;
Pham-Ledard, Anne;
Boubaya, Marouane;
Herms, Florian;
Celerier, Philippe;
Aubin, François;
Beneton, Nathalie;
Dinulescu, Monica;
Jannic, Arnaud;
Meyer, Nicolas;
Duval-Modeste, Anne-Bénédicte;
Cesaire, Laure;
Neidhardt, Ève-Marie;
Archier, Élodie;
Dréno, Brigitte;
Lesage, Candice;
Berthin, Clémence;
Kramkimel, Nora;
Grange, Florent

Publication type:

Article

Cemiplimab monotherapy as first‐line treatment of patients with brain metastases from advanced non–small cell lung cancer with programmed cell death‐ligand 1 ≥50%.

Published in:

Cancer (0008543X), 2025, v. 131, n. 10, p. 1, doi. 10.1002/cncr.35864

By:

Kilickap, Saadettin;
Özgüroğlu, Mustafa;
Sezer, Ahmet;
Gümüş, Mahmut;
Bondarenko, Igor;
Gogishvili, Miranda;
Turk, Haci M.;
Cicin, Irfan;
Bentsion, Dmitry;
Gladkov, Oleg;
Sriuranpong, Virote;
Quek, Ruben G. W.;
McIntyre, Debra A. G.;
He, Xuanyao;
McGinniss, Jennifer;
Seebach, Frank;
Gullo, Giuseppe;
Rietschel, Petra;
Pouliot, Jean‐Francois

Publication type:

Article

Erratum to "Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study".

Published in:: Cancer (0008543X), 2024, v. 130, n. 9, p. 1715, doi. 10.1002/cncr.35165
Publication type:: Article

Quality of life with cemiplimab plus chemotherapy for first‐line treatment of advanced non–small cell lung cancer: Patient‐reported outcomes from phase 3 EMPOWER‐Lung 3.

Published in:

Cancer (0008543X), 2023, v. 129, n. 14, p. 2256, doi. 10.1002/cncr.34687

By:

Makharadze, Tamta;
Quek, Ruben G. W.;
Melkadze, Tamar;
Gogishvili, Miranda;
Ivanescu, Cristina;
Giorgadze, Davit;
Dvorkin, Mikhail;
Penkov, Konstantin;
Laktionov, Konstantin;
Nemsadze, Gia;
Nechaeva, Marina;
Rozhkova, Irina;
Kalinka, Ewa;
Gessner, Christian;
Moreno‐Jaime, Brizio;
Passalacqua, Rodolfo;
Konidaris, Gerasimos;
Rietschel, Petra;
Gullo, Giuseppe

Publication type:

Article

Patient‐reported outcomes with cemiplimab monotherapy for first‐line treatment of advanced non–small cell lung cancer with PD‐L1 of ≥50%: The EMPOWER‐Lung 1 study.

Published in:

Cancer (0008543X), 2023, v. 129, n. 1, p. 118, doi. 10.1002/cncr.34477

By:

Gümüş, Mahmut;
Chen, Chieh‐I;
Ivanescu, Cristina;
Kilickap, Saadettin;
Bondarenko, Igor;
Özgüroğlu, Mustafa;
Gogishvili, Miranda;
Turk, Haci M.;
Cicin, Irfan;
Harnett, James;
Mastey, Vera;
Naumann, Ulrike;
Reaney, Matthew;
Konidaris, Gerasimos;
Sasane, Medha;
Brady, Keri J. S.;
Li, Siyu;
Gullo, Giuseppe;
Rietschel, Petra;
Sezer, Ahmet

Publication type:

Article

Management of myelofibrosis and concomitant advanced cutaneous squamous cell carcinoma with ruxolitinib associated with cemiplimab.

Published in:

2021

By:

Di Prima, Alessio;
Botticelli, Andrea;
Scalzulli, Emilia;
Colafigli, Gioia;
Pepe, Sara;
Lisi, Chiara;
Marchetti, Paolo;
Martelli, Maurizio;
Foà, Robin;
Breccia, Massimo

Publication type:

Letter

Evaluation of uveitis events in real-world patients receiving immune checkpoint inhibitors based on the FAERS database.

Published in:

Cutaneous & Ocular Toxicology, 2023, v. 42, n. 2, p. 68, doi. 10.1080/15569527.2023.2208661

By:

Fan, Qianqian;
Chen, Huan;
Hu, Yang;
Zhao, Bin

Publication type:

Article